Introduction
============

Mycobacteria species other than those of the *Mycobacterium tuberculosis* complex (MTBC) are called nontuberculous mycobacteria (NTM) or \"atypical\" mycobacteria. NTM are environmental organisms found in soil and water throughout the world[@B1],[@B2]. NTM are generally hardy, ubiquitous environmental bacteria that vary in geographic distribution and pulmonary pathogenicity. NTM can also cause disseminated disease[@B3]. Disseminated disease due to NTM is primarily associated with acquired immunodeficiency syndrome and other forms of severe immunosuppression[@B4]. However, the incidence of NTM disease in patients without human immunodeficiency virus infection is increasing[@B5].

Different NTM species have different antibiotic susceptibility patterns, and their resistance to anti-tuberculosis drugs is of particular importance. For these reasons, the accurate and early differential diagnosis of MTBC and NTM is required for optimal outcomes.

Currently, the identification of clinical isolates of mycobacteria at the species level is primarily based on the characteristics of the cultured bacteria and the biochemical test results. These conventional tests can take several weeks to perform and cannot always precisely identify the species[@B6]. Furthermore, these testing procedures are complex and laborious, and they are usually impeded by the slow growth of mycobacteria in culture. There are numerous species of NTM, and recently developed molecular methods have enabled the recognition of many of these species[@B7]. In this study, NTM were identified using a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method, based on the *rpoB* gene, at the Korean Institute of Tuberculosis[@B8],[@B9].

Mycobacterial identification at the species level is both of academic interest and of importance for gaining a better understanding of the organisms\' epidemiology and pathogenesis. Geographic variability in the environmental exposure and prevalence of NTM disease is of global significance[@B10].

Given these clinical challenges, further knowledge of the epidemiology of NTM in Korea is needed. The purpose of this study was to identify NTM and investigate their distribution in clinical specimens isolated from a tertiary teaching hospital in Cheonan, Korea.

Materials and Methods
=====================

This study included the isolation of NTM species from all clinical specimens referred to Dankook University Hospital Laboratory in Cheonan, Korea, from September 2005 to September 2011 ([Table 1](#T1){ref-type="table"}). Patients for whom NTM identification tests were requested provided samples of sputum and bronchial washing fluid. For this study, we retrospectively analyzed the results of these samples. Data were analyzed and categorized according to gender, age, and year of analysis.

1. Culture
----------

### 1) Sample pre-processing:

For respiratory samples, N-acetyl-L-cysteine (NALC)-NaOH solution (5% NaOH+ 0.5% NALC) was added to the sample to liquefy and decontaminate the mucous sputum. The solution was centrifuged at 3,000 ×g for 18 minutes at 4℃, and the supernatant was discarded. Phosphate buffered saline 1 mL was added after the sediment had been vortexed.

### 2) Mycobacterial culture:

The processed samples (0.2 mL) were used to inoculate 3% Ogawa medium (Eiken, Tokyo, Japan) and were cultured for 8 weeks in an incubator at 35-37℃ under 5-10% CO~2~. An interim report was provided at 4 weeks, if necessary.

Samples (0.5 mL each) were used to inoculate MGIT medium (Becton Dickinson, Sparks, MD, USA) after mixing with PANTA/supplement according to the manufacturer\'s protocol. The tubes were then incubated for 6 weeks in the BACTEC MGIT 960 system (Becton Dickinson). If fluorescence was detected in the tube, the test was considered positive.

2. NTM identification
---------------------

NTM identification was performed at the Korean Institute of Tuberculosis, where PCR-RFLP methods are used to target a novel region of the *rpoB* gene.

3. Statistical analysis
-----------------------

The statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA). The Cochran-Armitage test for trend was used to evaluate the tendency of isolating NTM from respiratory acid-fast bacilli (AFB)-culture specimens over the years studied.

Results
=======

1. Characteristics of NTM-positive patients
-------------------------------------------

A total of 25,133 specimens were received for AFB culture, of which 3,236 (12.9%) were AFB positive and 1,014 (4.0%) were NTM positive. A total of 267 samples from 186 patients were collected for NTM identification, and 232 samples from 157 patients were positive for NTM species ([Table 1](#T1){ref-type="table"}).

Gender analysis showed that 66.7% of all patients were men, and that 65.6% of the NTM-positive patients were men. The average patient age was 63.3 years (range, 33.3-91.1 years). More than 50% of patients were aged 60-79 years ([Figure 1](#F1){ref-type="fig"}).

2. Distribution of NTM species
------------------------------

*Mycobacterium avium* complex (MAC), the most common NTM, was detected in 153 samples (65.9%): *M. intracellulare* was detected in 119 and *M. avium* in 34 samples. *M. kansasii* was the next most prevalent species (18 isolates, 7.8%), followed by *M. abscessus* complex (*M. abscessus* and *M. massiliense*; 15 isolates, 6.5%) and *M. gordonae* (12 isolates, 5.2%) ([Table 2](#T2){ref-type="table"}). The annual distributions of NTM species are detailed in [Table 3](#T3){ref-type="table"}.

The overall proportion of NTM isolates from among the respiratory AFB-positive specimens was 31.3% (1,014/3,236); the highest rate was seen in 2011 (192/433, 44.3%), followed by 2009 (135/361, 37.4%) and 2010 (246/662, 37.2%). There was an upward trend in NTM proportion in respiratory specimens during the study period (Cochran-Armitage test for trend, p\<0.001) ([Figure 2](#F2){ref-type="fig"}).

Discussion
==========

NTM are ubiquitous in the environment, and are found in water, soil, and air, as well as in animal-derived materials. Currently, more than 140 species of NTM are known[@B11], and 50 species have been identified as opportunistic pathogens in humans[@B12]. NTM isolation and disease prevalence seems to be increasing worldwide[@B13]-[@B15], and in Korea[@B16]-[@B18]. We assessed NTM species distribution and epidemiologic trends from isolates during 2005-2011 in the Cheonan area of Korea.

In the study by Lee et al.[@B19], the gender ratio of patients with NTM disease was close to 1 (male:female ratio of 1.07:1). The study by Choi et al.[@B20], on the other hand, found a male:female ratio of 2.56:1. Our results (male:female ratio of 1.91:1) lead us to conclude that NTM is not strongly associated with gender, but rather depends more on region and timing.

In our study, the average age was 63.3 years: 28.0% of patients were aged 60-69 years, and 23.6% were aged 70-79 years. The average patient age in other studies of NTM disease were as follows: 48.7 years in the study by Baek et al.[@B21] performed in 1998-1999, 53 years in the study by Lee et al.[@B19] performed in 1999, 58 years in the study by Choi et al.[@B20] performed in 2002-2003, 58.7 years in the study by Lee et al.[@B22] performed in 2002-2003, and 61 years in the study by Kim et al.[@B23] performed in 2003. From these results, it appears that the average age of patients with NTM has been increasing since the late 1990s. Further research is warranted to investigate this phenomenon.

In this study, NTM species were more commonly isolated from men than from women; however, NTM was not strongly associated with gender, but rather depended more on region and timing. The average age of patients with NTM has been increasing since the late 1990s. The variation in rates reported by different hospitals may be due to variations in patient group characteristics, research periods, the specimen collection and detection methods used, and NTM detection thresholds.

The NTM species in the 232 samples in this study were as follows: *M. intracellulare* (119 samples, 51.3%), *M. avium* (34, 14.7%), and *M. kansasii* (18, 7.8%). In a study performed in Seoul[@B17], MAC was found in 138 of the 328 samples (42.1%), while other identified species included *M. fortuitum* (64, 15.2%), *M. abscessus* (37, 11.3%), and *M. gordonae* (33, 10.1%). However, in a study conducted in the Masan[@B20] area, MAC was found in 55 of 100 samples (55%), while other species included *M. abscessus* (25, 25%), *M. fortuitum* (9, 9%), and *M. chelonae* (8, 8%). In a study from Ulsan[@B5], 22.7% of isolates from a total of 384 samples were identified as MAC, while 15.9% were *M. kansasii*, 11.5% were *M. gordonae*, and 8.9% were *M. fortuitum*. In a study conducted in Hong Kong[@B24], 19% of detected species were *M. gordonae*, 15% were *M. terrae*, 12% were *M. fortuitum*, and 5% were *M. chelonae*. A Danish survey[@B25] found that 55.3% of NTM isolates were *M. gordonae*, 19.3% were MAC, 4.8% were *M. fortuitum*, and 3.9% were *M. abscessus*. Finally, a US study[@B26] reported rates of 80.1% for MAC, 12.1% for *M. chelonae/abscessus*, 5.6% for *M. fortuitum*, and 5.5% for *M. kansasii*. *M. gordonae* is often regarded as a contaminant[@B7], although infections due to *M. gordonae* have been reported in some patients, such as those in an immunocompromised state[@B27],[@B28]. Our results are quite different from those of studies performed in other countries, which further suggests that NTM disease depends on the characteristics of regional populations[@B29].

In this study, NTM were found in 232 samples (7.17% positive rate in cultured specimens). The positive rate in Korea[@B30],[@B31] in the 1960s was \<1%. In 1970, Kim et al.[@B30] identified NTM species in sputum at a rate of 2.7%. More recently, NTM isolation rates in cultured specimens have been found to be approximately 10-30%, as represented by those from Seoul Asan Hospital[@B32] (21.9%) in 2002, Seoul National University (SNU) Hospital[@B9] (21.5%) in 2006, Fatima Hospital[@B33] (7.9%) in 2009, and Gil Hospital[@B34] (19.4%) in 2012. The variation in rates reported by different hospitals may be due to variations in patient group characteristics, research periods, specimen collection and detection methods used, and NTM detection thresholds.

Along with increases in the proportion of NTM isolates reported from referred specimens, the NTM ratio of respiratory AFB culture-positive specimens also increased between 2005 and 2011. Overall, an upward trend in NTM incidence was found during the study period.

Given these clinical challenges, further knowledge of the epidemiology of NTM in Korea is needed. Such knowledge will be beneficial in the treatment of NTM disease and the development of clinical science.
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###### 

Basic statistics of AFB culture and NTM identifications

![](trd-74-215-i001)

^\*^Positive rate of AFB culture: positive culture results/referred tests in specimens or patients. ^†^Rate of NTM identification to AFB culture-positive results: positive NTM results/AFB culture-positive results in specimens or patients.

AFB: acid-fast bacilli; NTM: nontuberculous mycobacteria.

###### 

Distribution of species after nontuberculous mycobacteria (NTM) identification according to specimens and patients
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^\*^*M. abscessus* complex: *M. abscessus* and *M. massiliense*. ^†^Other species: *M. szulgai*, *M. chelonae*, *M. ulcerans*, *M. nonchromogenicum*, *M. peregrinum*, and *M. simiae*.

###### 

Annual incidence of nontuberculous mycobacteria (NTM) species
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^\*^*M. abscessus* complex: *M. abscessus* and *M. massiliense*. ^†^Other species: *M. szulgai*, *M. chelonae*, *M. ulcerans*, *M. nonchromogenicum*, *M. peregrinum*, and *M. simiae*.
